Lexicon Pharmaceuticals
LXRX
$1.58
Share price
-0.32%
Change (1 day)
-34.10%
Change (1 year)
Categories
Lexicon Pharmaceuticals (LXRX) - Total assets
Total assets on the balance sheet as of December 2023 : $0.22 B
According to Lexicon Pharmaceuticals 's latest financial reports the company's total assets are $0.22 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Lexicon Pharmaceuticals - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.19 B | 41.92% |
| 2021-12-31 | $0.13 B | -32.82% |
| 2020-12-31 | $0.20 B | -51.21% |
| 2019-12-31 | $0.41 B | 47.01% |
| 2018-12-31 | $0.28 B | -34.91% |
| 2017-12-31 | $0.43 B | -8.22% |
| 2016-12-31 | $0.47 B | -27.05% |
| 2015-12-31 | $0.65 B | 38.31% |
| 2014-12-31 | $0.47 B | 71.93% |
| 2013-12-31 | $0.27 B | -26.26% |
| 2012-12-31 | $0.37 B | -13.64% |
| 2011-12-31 | $0.43 B | 17.34% |
| 2010-12-31 | $0.36 B | 42.33% |
| 2009-12-31 | $0.25 B | -1.43% |
| 2008-12-31 | $0.26 B | -29.19% |
| 2007-12-31 | $0.36 B | 94.09% |
| 2006-12-31 | $0.19 B | -13.01% |
| 2005-12-31 | $0.21 B | 3.18% |
| 2004-12-31 | $0.21 B | -25.41% |
| 2003-12-31 | $0.28 B | 40.85% |
| 2002-12-31 | $0.20 B | -15.92% |
| 2001-12-31 | $0.23 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $98.72 B | 42,931.18% | 🇺🇸 USA |
 Illumina ILMN | $10.11 B | 4,307.03% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $33.08 B | 14,318.49% | 🇺🇸 USA |
 Ultragenyx RARE | $1.49 B | 549.88% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.78 B | 243.12% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.20 B | -10.30% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.37 B | 63.71% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.84 B | 2,882.01% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $49.13 M | -78.59% | 🇺🇸 USA |